Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS (Q73276254)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

E Waubant

1 reference

2 November 2019

L Gee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Bacchetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Sloan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Cotleur

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Rudick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Goodkin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

139-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

A serial study of new MS lesions and the white matter from which they arise

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

A pilot study of MRI activity before and during interferon beta-1a therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Effects of acquisition device, sampling rate, and record length on kinocardiography during position-induced haemodynamic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

Rapid Automated Algorithm for Aligning and Reslicing PET Images

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

MRI-PET registration with automated algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900355-6

7 January 2021

10.1016/S0165-5728(00)00355-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108942%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference